stephane Audebert

Dr. stephane Audebert

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2005 in Oncogene
Verified
Journal Article
Closed access
PDF file
CNChristel Navarro
Christel Navarro
SNSébastien Nola
Sébastien Nola
SAstephane Audebert
stephane Audebert
MSMarie-Josée Santoni
Marie-Josée Santoni
JAJean-Pierre Arsanto
Jean-Pierre Arsanto
JBJean-Paul Borg
Jean-Paul Borg

19 January 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
SGSandeep Gopal
Sandeep Gopal
LVLaurence Veracini
Laurence Veracini
DGDominique Grall
Dominique Grall
CBCatherine Butori
Catherine Butori
SSSébastien Schaub
Sébastien Schaub
EOEllen Van Obberghen-Schilling
Ellen Van Obberghen-Schilling
Functional interplay between tumour cells and their neoplastic extracellular matrix plays a decisive role in malignant progression of carcinomas. Here we provide a comprehensive data set of the human HNSCC-associated fibroblast matrisome. Although much attention has been paid to the deposit of collagen, we identify oncofetal fibronectin (FN) as a major and obligate component of the matrix assembled by stromal fibroblasts from head and neck squamous cell carcinomas (HNSCC). FN overexpression in tumours from 435 patients corresponds to an independent unfavourable prognostic indicator. We show that migration of carcinoma collectives on fibrillar FN-rich matrices is achieved through αvβ6 and α9β1 engagement, rather than α5β1. Moreover, αvβ6-driven migration occurs independently of latent TGF-β activation and Smad-dependent signalling in tumour epithelial cells. These results provide insights into the adhesion-dependent events at the tumour–stroma interface that govern the collective mode of migration adopted by carcinoma cells to invade surrounding stroma in HNSCC.

1 June 2004 in Current Biology
Verified
Journal Article
Closed access
SAstephane Audebert
stephane Audebert
CNChristel Navarro
Christel Navarro
CNClaire Nourry
Claire Nourry
SCSylvette Chasserot-Golaz
Sylvette Chasserot-Golaz
PLPatrick Lécine
Patrick Lécine
JBJean-Paul Borg
Jean-Paul Borg

1 January 2009 in Blood
Verified
Journal Article
Open access
PDF file
MEMira Ernkvist
Mira Ernkvist
NPNathalie Luna Persson
Nathalie Luna Persson
SAstephane Audebert
stephane Audebert
PLPatrick Lécine
Patrick Lécine
ISIndranil Sinha
Indranil Sinha
LHLars Magnus Holmgren
Lars Magnus Holmgren
Controlled regulation of Rho GTPase activity is an essential component mediating growth factor–stimulated migration. We have previously shown that angiomotin (Amot), a membrane-associated scaffold protein, plays a critical role during vascular patterning and endothelial migration during embryogenesis. However, the signaling pathways by which Amot controls directional migration are not known. Here we have used peptide pull-down and yeast 2-hybrid (Y2H) screening to identify proteins that interact with the C-terminal PDZ-binding motifs of Amot and its related proteins AmotL1 and 2. We report that Amot and its related proteins bind to the RhoA GTPase exchange factor (RhoGEF) protein Syx. We show that Amot forms a ternary complex together with Patj (or its paralogue Mupp1) and Syx. Using FRET analysis, we provide evidence that Amot controls targeting of RhoA activity to lamellipodia in vitro. We also report that, similar to Amot, morpholino knockdown of Syx in zebrafish results in inhibition of migration of intersegmental arteries. Taken together, our results indicate that the directional migration of capillaries in the embryo is governed by the Amot:Patj/Mupp1:Syx signaling that controls local GTPase activity.

30 April 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
MTMélanie Tichet
Mélanie Tichet
VPVirginie Prod’homme
Virginie Prod’homme
NFNina Fenouille
Nina Fenouille
DADamien Ambrosetti
Damien Ambrosetti
AMAude Mallavialle
Aude Mallavialle
STSophie Tartare-Deckert
Sophie Tartare-Deckert
Disruption of the endothelial barrier by tumour-derived secreted factors is a critical step in cancer cell extravasation and metastasis. Here, by comparative proteomic analysis of melanoma secretomes, we identify the matricellular protein SPARC as a novel tumour-derived vascular permeability factor. SPARC deficiency abrogates tumour-initiated permeability of lung capillaries and prevents extravasation, whereas SPARC overexpression enhances vascular leakiness, extravasation and lung metastasis. SPARC-induced paracellular permeability is dependent on the endothelial VCAM1 receptor and p38 MAPK signalling. Blocking VCAM1 impedes melanoma-induced endothelial permeability and extravasation. The clinical relevance of our findings is highlighted by high levels of SPARC detected in tumour from human pulmonary melanoma lesions. Our study establishes tumour-produced SPARC and VCAM1 as regulators of cancer extravasation, revealing a novel targetable interaction for prevention of metastasis.

31 July 2009 in Circulation Research
Verified
Journal Article
Closed access
PDF file
YZYujuan Zheng
Yujuan Zheng
SVSimona Vertuani
Simona Vertuani
SNStaffan Nyström
Staffan Nyström
SAstephane Audebert
stephane Audebert
IMInèz Meijer
Inèz Meijer
LHLars Holmgren
Lars Holmgren
Rationale: We have previously shown that angiomotin (Amot) is essential for endothelial cell migration during mouse embryogenesis. However, ≈5% of Amot knockout mice survived without any detectable vascular defects. Angiomotin-like protein 1 (AmotL1) potentially compensates for the absence of Amot as it is 62% homologous to Amot and exhibits similar expression pattern in endothelial cells. Objective: Here, we report the identification of a novel isoform of AmotL1 that controls endothelial cell polarization and directional migration. Methods and Results: Small interfering RNA–mediated silencing of AmotL1 in mouse aortic endothelial cells caused a significant reduction in migration. In confluent mouse pancreatic islet endothelial cells (MS-1), AmotL1 colocalized with Amot to tight junctions. Small interfering RNA knockdown of both Amot and AmotL1 in MS-1 cells exhibited an additive effect on increasing paracellular permeability compared to that of knocking down either Amot or AmotL1, indicating both proteins were required for proper tight junction activity. Moreover, as visualized using high-resolution 2-photon microscopy, the morpholino-mediated knockdown of amotl1 during zebrafish embryogenesis resulted in vascular migratory defect of intersegmental vessels with strikingly decreased junction stability between the stalk cells and the aorta. However, the phenotype was quite distinct from that of amot knockdown which affected polarization of the tip cells of intersegmental vessels. Double knockdown resulted in an additive phenotype of depolarized tip cells with no or decreased connection of the stalk cells to the dorsal aorta. Conclusions: These results cumulatively validate that Amot and AmotL1 have similar effects on endothelial migration and tight junction formation in vitro. However, in vivo Amot appears to control the polarity of vascular tip cells whereas AmotL1 mainly affects the stability of cell–cell junctions of the stalk cells.